Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

PRP can reduce pain and improve function, but more standardized research is needed.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Insulin resistance linked to obesity may increase COVID-19 severity.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.